Skip to content
November 15, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Breast Cancer Surgery and Reconstruction
  • A New Era of Leadership: Dr. Lynn A. Damitz Takes the Helm of the American Society of Plastic Surgeons
  • Breast Cancer Surgery and Reconstruction

A New Era of Leadership: Dr. Lynn A. Damitz Takes the Helm of the American Society of Plastic Surgeons

Basiran November 15, 2026 8 minutes read
a-new-era-of-leadership-dr-lynn-a-damitz-takes-the-helm-of-the-american-society-of-plastic-surgeons

HOUSTON – In a pivotal moment for the field of aesthetic and reconstructive medicine, the American Society of Plastic Surgeons (ASPS)—the world’s largest and most influential organization of board-certified plastic surgeons—has officially inaugurated Lynn A. Damitz, MD, FACS, as its new President. The transition took place during "Plastic Surgery The Meeting," the Society’s marquee annual scientific conference held in Houston, marking the beginning of a one-year term that will extend through September 19, 2027.

Dr. Damitz, a distinguished leader at the University of North Carolina (UNC) School of Medicine, steps into this role at a time when the specialty is navigating rapid technological evolution, shifting healthcare policy landscapes, and an increasing public demand for safety and transparency in cosmetic and reconstructive procedures.


Main Facts: A Leader at the Intersection of Innovation and Advocacy

The appointment of Dr. Damitz is widely viewed by industry experts as a strategic move toward a more data-driven future for plastic surgery. As the new President of the ASPS, she is tasked with steering an organization that represents thousands of surgeons globally. Her presidency is not merely ceremonial; she inherits a complex agenda focused on establishing rigorous quality metrics, fostering global surgical collaboration, and advocating for patient rights at the legislative level.

"I am deeply honored to lead the American Society of Plastic Surgeons and represent our dedicated members worldwide," Dr. Damitz stated following her inauguration. "As plastic surgeons, our responsibility extends beyond the operating room. Patient safety must guide every decision we make, from education to innovation. I look forward to supporting the work of board-certified plastic surgeons and reinforcing our specialty’s leadership in delivering exceptional patient outcomes."

Dr. Damitz brings a wealth of clinical experience to the presidency. Currently serving as the Chief of the Division of Plastic and Reconstructive Surgery and Director of Aesthetic Surgery at the UNC School of Medicine, her practice spans the breadth of the specialty, including facial and body aesthetic surgery, complex breast and oncologic reconstruction, and the management of facial trauma.


Chronology: A Career Built on Service and Scientific Rigor

Dr. Damitz’s path to the presidency is the culmination of over two decades of persistent engagement with the ASPS and the broader surgical community.

Early Education and Foundation

Dr. Damitz earned her medical degree from the Hahnemann University School of Medicine. Her surgical foundation was established at the University of North Carolina at Chapel Hill, where she completed both her general surgery and plastic surgery residencies. Following her residency, she sought advanced specialization, completing highly competitive fellowships in plastic, breast, and aesthetic surgery—training that provided the bedrock for her future reputation as an expert in reconstructive techniques.

Engagement with the ASPS (2002–Present)

Since joining the ASPS in 2002, Dr. Damitz has been a constant presence in the Society’s committee structure. Her ascent to the presidency was marked by several key milestones:

  • Membership Leadership: She served as the chair of the ASPS Membership Committee for three years, a role that gave her deep insight into the needs and professional challenges of the Society’s diverse membership base.
  • Policy and Advocacy: Her most significant contributions prior to the presidency were as ASPS Board Vice President for Health Policy and Advocacy. In this capacity, she was a primary architect behind the push to modernize the Women’s Health and Cancer Rights Act (WHCRA). Her efforts were instrumental in expanding insurance coverage for breast reconstruction and ensuring that patients with congenital conditions have equitable access to care.
  • The Houston Appointment (2026): Her elevation to President at the Houston conference serves as the capstone of a twenty-four-year journey of institutional service.

Supporting Data: The Pillars of Her Presidential Agenda

Dr. Damitz has signaled that her term will be defined by three core pillars: quality metrics, outcomes-based data, and enhanced patient access.

1. The Data-Driven Surgical Standard

In an era where aesthetic surgery is heavily influenced by social media, Dr. Damitz aims to refocus the industry on clinical outcomes. She plans to champion the use of standardized quality metrics. By leveraging the ASPS’s extensive databases, she intends to help surgeons benchmark their own performance against national standards. This move is designed to reduce variability in surgical outcomes and ensure that patients receive the highest standard of care regardless of their geographical location.

2. Modernizing Health Policy

Dr. Damitz’s history as an advocate will be central to her tenure. She remains deeply committed to the multidisciplinary initiatives focused on breast surgery, ensuring that as surgical techniques evolve, so too does the regulatory framework. Her focus on "modernizing" policy suggests a proactive approach to legislative advocacy, particularly regarding the intersection of insurance reimbursement and reconstructive surgery.

3. Education and Professional Development

As a Professor of Surgery, Dr. Damitz views education as the primary tool for mitigating risk. She has expressed a strong commitment to mentoring the next generation of plastic surgeons, emphasizing that professional leadership and ethical practice are as vital as technical surgical proficiency.


Official Responses: Industry Perspective on the Appointment

The announcement of Dr. Damitz’s presidency has been met with widespread support from the surgical community. Peer leaders within the ASPS have lauded her appointment, noting that her background in both academic medicine and political advocacy makes her uniquely qualified to address the challenges facing modern surgery.

"Dr. Damitz possesses the rare combination of technical mastery and policy acumen," noted a member of the ASPS Board of Directors. "In an environment where the ‘business’ of plastic surgery is often conflated with the ‘practice’ of plastic surgery, she is a voice of reason who consistently prioritizes the patient experience over market trends."

Colleagues at the University of North Carolina have also highlighted her role as a mentor. "Lynn has always been a bridge-builder," says a senior faculty member at UNC. "She understands that the future of plastic surgery relies on the ability of different sub-specialties—aesthetic, reconstructive, and trauma—to share data and learn from one another."


Implications: The Future of the Specialty

The implications of Dr. Damitz’s term are significant for both the medical community and the public.

For the Medical Community

The focus on outcomes-based data will likely lead to a shift in how plastic surgery fellowships and continuing education programs are structured. By prioritizing quantitative data, Dr. Damitz is effectively encouraging a culture of "continuous improvement" within the specialty. This could lead to a decrease in complication rates and a more standardized approach to complex reconstructive procedures.

For the Patient

Patients are the ultimate beneficiaries of the agenda set forth by Dr. Damitz. Her commitment to improving access to care means that the ASPS will likely increase its lobbying efforts for insurance parity in reconstructive surgery. For individuals seeking breast reconstruction or those requiring complex congenital repairs, this could translate into easier navigation of the healthcare system and reduced financial barriers to necessary procedures.

Global Impact

As the leader of an international organization, Dr. Damitz will also focus on global partnership. Plastic surgery is a rapidly globalizing field, and Dr. Damitz’s platform includes plans for international collaboration on safety protocols. By aligning international standards of care, the ASPS aims to ensure that patients worldwide, regardless of where they undergo surgery, can expect the same rigorous safety standards that define board-certified plastic surgery in the United States.


Conclusion: A Vision for the Future

As Dr. Damitz assumes her position, the American Society of Plastic Surgeons finds itself at a crossroads. The demand for plastic surgery, particularly in the aesthetic realm, has never been higher, yet the challenges regarding patient safety, data transparency, and healthcare policy have never been more complex.

Dr. Lynn A. Damitz brings to the presidency a vision that is both grounded and ambitious. By fostering a culture where education and innovation are guided by patient safety and outcomes, she is well-positioned to steer the specialty through a transformative year. Her tenure is set to be defined not just by the policies she implements, but by the legacy of professionalism and patient-centered advocacy she leaves behind when her term concludes in September 2027.

As she takes the podium, the message is clear: the future of plastic surgery is one where precision, safety, and equity are the standards by which excellence is measured. Under the guidance of Dr. Damitz, the ASPS is poised to not only meet these challenges but to define the next generation of surgical leadership.

About the Author

Basiran

Author

View All Posts

Post navigation

Previous: Digital Pathology’s New Frontier: Mining Historical Tissue to Revolutionize Preclinical Research

Related Stories

beyond-the-limits-of-reconstruction-the-worlds-first-combined-face-and-whole-eye-transplant
  • Breast Cancer Surgery and Reconstruction

Beyond the Limits of Reconstruction: The World’s First Combined Face and Whole-Eye Transplant

Raul Delapena Setiawan November 15, 2026
shaping-the-future-of-aesthetics-asps-and-medtech-innovator-unveil-2026-accelerator-cohort
  • Breast Cancer Surgery and Reconstruction

Shaping the Future of Aesthetics: ASPS and MedTech Innovator Unveil 2026 Accelerator Cohort

Neng Nana November 14, 2026
bridging-the-gap-how-the-asps-medtech-innovator-partnership-is-revolutionizing-surgical-care
  • Breast Cancer Surgery and Reconstruction

Bridging the Gap: How the ASPS-MedTech Innovator Partnership is Revolutionizing Surgical Care

Nana Muazin November 14, 2026

Recent Posts

  • A New Era of Leadership: Dr. Lynn A. Damitz Takes the Helm of the American Society of Plastic Surgeons
  • Digital Pathology’s New Frontier: Mining Historical Tissue to Revolutionize Preclinical Research
  • Unraveling the Neural Tapestry of Cancer: Oklahoma Researchers Discover How Aggressive Breast Tumors Recruit Nerves to Fuel Growth
  • AHA26: Kerendia shows efficacy in heart failure across kidney failure risk strata
  • Beyond the Pink: Navigating Breast Cancer Awareness Month for Meaningful Impact

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

a-new-era-of-leadership-dr-lynn-a-damitz-takes-the-helm-of-the-american-society-of-plastic-surgeons
  • Breast Cancer Surgery and Reconstruction

A New Era of Leadership: Dr. Lynn A. Damitz Takes the Helm of the American Society of Plastic Surgeons

Basiran November 15, 2026
digital-pathologys-new-frontier-mining-historical-tissue-to-revolutionize-preclinical-research
  • Chemotherapy and Targeted Therapy

Digital Pathology’s New Frontier: Mining Historical Tissue to Revolutionize Preclinical Research

Laily UPN November 15, 2026
unraveling-the-neural-tapestry-of-cancer-oklahoma-researchers-discover-how-aggressive-breast-tumors-recruit-nerves-to-fuel-growth
  • Medical Research and Clinical Trials

Unraveling the Neural Tapestry of Cancer: Oklahoma Researchers Discover How Aggressive Breast Tumors Recruit Nerves to Fuel Growth

Raul Delapena Setiawan November 15, 2026
aha26-kerendia-shows-efficacy-in-heart-failure-across-kidney-failure-risk-strata
  • Medical Research and Clinical Trials

AHA26: Kerendia shows efficacy in heart failure across kidney failure risk strata

Suro Senen November 15, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.